Clinical Trial Update: Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing varying regimens of CANDIN for common warts (verruca vulgaris) with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Warts
• Verruca Vulgaris

Drugs mentioned

• Candin

Snippet

Sponsor: Nielsen BioSciences, Inc. | Conditions: Warts | Phase 2 | Status: COMPLETED | Results posted: 2019-06-04